Refresh

DR.REDDY'S LABORATORIES LTD. - Dr Reddys Laboratories Ltd reply to clarification sought by the exchange


30 Jun 2015
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing in Financial Chronicle on June 30, 2015 titled "DRL pulls out drugs from US"<BR><BR>Dr Reddys Laboratories Ltd replied stating "We have initiated a voluntary recall of Divalproex. This has been done as an abundant precautionary measure by the Company, based on observations related to the products' dissolution specifications. The observations are being investigated at our end and we are confident of a satisfactory resolution at the earliest. Pending submission of the investigation report to the USFDA, we would not like to comment further at this stage.<BR><BR>The overall impact on the Company's financials of this development is expected to be quite insignificant."

Source: BSE India

View all announcements for DR.REDDY'S LABORATORIES LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com